Results 101 to 110 of about 16,718 (212)

Effects of Protein-Energy Wasting (PEW) and hyperphosphatemia on the prognosis in Japanese maintenance hemodialysis patients : A five-year follow-up observational study [PDF]

, 2020
Background & aims: In dialysis patients, malnutrition is a poor prognostic factor. In patients with chronic kidney disease (CKD), malnutrition is qualitatively different from general malnutrition, which is defined as “Protein-Energy Wasting (PEW ...
Inoue, Arisa, イシカワ, エイジ, 30397830, ミキ, チカオ, ハマノ イノウエ, アリサ, シライ, ユミコ, Shirai, Yumiko, 濱野(井上), 愛莉沙, ムラタ, トモヒロ, 濵田, 康弘, 631, Ishikawa, Eiji, Miki, Chikao, Murata, Tomohiro, Hamada, Yasuhiro, ハマダ, ヤスヒロ, 261537/profile-ja.html   +16 more
core  

Cost-Effectiveness Analysis for the Treatment of Hyperphosphatemia in Predialysis Patients: Calcium-Based versus Noncalcium-Based Phosphate Binders

, 2018
Background. Hyperphosphatemia in chronic kidney disease (CKD) patients is often treated with calcium carbonate (CaCO3) despite the fact that CaCO3 is associated with increased calcium load and potentially increased cardiovascular risk.
A. Soraya, K. L. Ang, B. L. Goh, A. Goh
core   +1 more source

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats

Hyperphosphatemia and secondary hyperparathyroidism (SHPT) are the common complications found in CKD that lead to severe complications including mineral bone disease (MBD), vascular calcification (VC), and cardiovascular mortality.
Rath Pitchyangkura, Weerapat Anegkamol, Somying Tumwasorn, Thana Thongsricome, Maroot Kaewwongse, Mana Taweevisit, Natthaya Chuaypen, Thasinas Dissayabutra, Wirin Bowonsomsarit, Piyaratana Tosukhowong   +9 more
core   +1 more source

Safety and Phosphate‐Binding Capacity of Oxylanthanum Carbonate in Healthy Volunteers

Clinical and Translational Science
Despite the widespread use of currently available serum phosphate management options, elevated serum phosphate is common in patients with end‐stage kidney disease on dialysis.
Pablo E. Pergola, Melanie S. Joy, Armando Garsd, Steve J. Hasal, Atul Khare, Guru Reddy, Pramod Gupta, William F. Finn   +7 more
doaj   +1 more source

Hyperphosphatemia

Saudi Medical Journal, 2015
Hyperphosphatemia is a major cause of morbidity and mortality in patients with chronic kidney disease. The association between hyperphosphatemia and increased risk of death from cardiovascular disease/vascular calcification has been well established for a long time.
openaire   +2 more sources

Clinical Evaluation of Low-Dose Magnesium Carbonate as a Phosphate Binder in Chronic Hemodialysis Patients

Life
Background and Objectives: Hyperphosphatemia is a key component of chronic kidney disease-mineral and bone disorder and is associated with higher rates of cardiovascular events and mortality in patients undergoing dialysis.
Valeri Tzekov, Tanya Kostadinova, Elizabet Artinyan, Rumyana Stoyanova, Evelina Valcheva, Nikolay Dimov   +5 more
doaj   +1 more source

Analysis and Nursing Health Education of Current Status of Maintenance Hemodialysis Patients with Hyperphosphatemia

, 2020
Concerned about the current situation of hemodialysis patients' awareness of the problems related to dialysis complicated with hyperphosphatemia, further analyze the existing problems and causes, give targeted and individualized health education, improve
Xu, Hongjiao, Bi, Yingyi, He, Wenwen, Zhao, Xing, Gao, Liqian   +4 more
core  

Patient Empowerment in the Management of Hyperphosphatemia

, 2007
Despite advances in dialysis technology and an increasing variety of effective phosphate binders (PB) target phosphate levels are achieved in only a minority of ESRD patients.
S. Hoechst, I. Landthaler, M. K Kuhlmann
core   +1 more source

Evaluation On Self-Adjusted Phosphate Binder Administration To Dietary Phosphate Contents In Management Of Hyperphosphatemia Among Hemodialysis Patients In Penang, Malaysia [PDF]

, 2018
Hyperphosphatemia is a serious problem that is associated with high mortality rate among the dialysis patient. Many studies have revealed that the dialysis and dietary restriction are insufficient for managing hyperphosphatemia. Thus, phosphate binder is
Khor, Su Mee
core   +1 more source

Hyperphosphatemia [PDF]

, 2020
openaire   +1 more source